Contribution: Industrial Research Assistance Program – Contributions to Firms
Diagnostics Biochem Canada Inc.
$275,000.00
Design and development of nanobead-based chemiluminescence immunoassays for automated analyzers
EF 2023-24 · 2023-07-04
Résumé
Global Automated Immunoassay Analyzers market is valued at USD 11.53 Billion in 2022 and is projected to attain a value of USD 35.99 Billion by 2030 at a CAGR of 15.30% during the forecast period, 2022–2028 (https://www.vantagemarketresearch.com/industry-report/automated-immunoassay-analyzers-market-1314).. Automated analyzers are one of the main diagnostic platforms in Canada and other developed nations. In line with this market trend, DBC will transfer vital diagnostic hormone assays, a field in which it is a global market leader, from a microplate-based platform to higher throughput automated systems. This initiative will expand the addressable market both locally and globally for DBC products providing sustained double-digit growth well into the future.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
London|London, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
123926966
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2023-07-04 | 2023-24 | $275,000.00 |
| 3 | 2023-07-04 | 2023-24 | $275,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 276 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 276 jours.
Agreement End Date
2025-03-31
Agreement Number
1009243
Agreement Start Date
2023-07-04
Agreement Title
Design and development of nanobead-based chemiluminescence immunoassays for automated analyzers
Agreement Title (French)
Conception et développement d’immunodosages par chimiluminescence à base de nanobilles pour les analyseurs automatisés
Agreement Type
Contribution
Agreement Value
$275,000.00
Amendment Date
2024-08-02
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Global Automated Immunoassay Analyzers market is valued at USD 11.53 Billion in 2022 and is projected to attain a value of USD 35.99 Billion by 2030 at a CAGR of 15.30% during the forecast period, 2022–2028 (https://www.vantagemarketresearch.com/industry-report/automated-immunoassay-analyzers-market-1314).. Automated analyzers are one of the main diagnostic platforms in Canada and other developed nations. In line with this market trend, DBC will transfer vital diagnostic hormone assays, a field in which it is a global market leader, from a microplate-based platform to higher throughput automated systems. This initiative will expand the addressable market both locally and globally for DBC products providing sustained double-digit growth well into the future.
Description (French)
Le marché mondial des analyseurs automatisés d’immunoessais est évalué à 11,53 milliards USD en 2022 et devrait atteindre une valeur de 35,99 milliards USD d’ici 2030 à un TCAC de 15,30% au cours de la période de prévision, 2022-2028 (https://www.vantagemarketresearch.com/industry-report/automated-immunoassay-analyzers-market-1314).... Les analyseurs automatisés sont l’une des principales plateformes de diagnostic au Canada et dans d’autres pays développés. Conformément à cette tendance du marché, DBC transférera les dosages hormonaux diagnostiques vitaux, un domaine dans lequel elle est leader du marché mondial, d’une plateforme basée sur des microplaques à des systèmes automatisés à plus haut débit. Cette initiative permettra d’élargir le marché potentiel des produits de DBC, tant au niveau local que mondial, et d’assurer une croissance soutenue à deux chiffres pour l’avenir.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
London--Fanshawe
Federal Riding (French)
London--Fanshawe
Federal Riding Number
35051
NAICS Code
621510
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
123926966
Recipient City
London|London
Recipient Country
CA
Recipient Legal Name
Diagnostics Biochem Canada Inc.
Recipient Operating Name
DBC Labs
Recipient Postal Code
N6M 1A1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2023-2024-Q3-1009243
